Stock listing
Lang & Schwarz:A41083 VivoSim Labs, Inc. Aktie
German listing (Lang & Schwarz) of VivoSim Labs, Inc. · home listing NASDAQ:VIVS
Follow VivoSim Labs, Inc. into a list and get an email when it puts out news.
Home listing price · NASDAQ:VIVS
$0.142 USD +0.000 (+0.1%)
Close on Nov 6, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:VIVS
- Day range
- $0.140 – $0.145 USDNov 6, 2026
- Volume
- 160,353 sharesNov 6, 2026
- Market cap
- $2.35M USDAt the close on Nov 6, 2026 · price × 16.59M shares outstanding
- 52-week range
- $0.136 – $3.400 USDLowest and highest trades, Nov 7, 2025 – Nov 6, 2026
- Traded on an average day
- $969,381 USDMedian day 647,874 shares · last 3 months, Aug 6, 2026 – Nov 6, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:VIVS · Home | $0.142 USD | +0.000 (+0.1%) | 160,353 | $0.142 | $0.145 | $0.140 | $0.142 | Close on Nov 6, 2026 |
Daily closes
Last 3 months, Aug 6, 2026 – Nov 6, 2026 · NASDAQ:VIVS · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $0.142 | +0.000 | +0.1% | $0.142 | $0.145 | $0.140 | 160,353 | |
| $0.142 | -0.011 | -7.0% | $0.148 | $0.152 | $0.136 | 525,025 | |
| $0.152 | +0.009 | +6.0% | $0.155 | $0.155 | $0.145 | 535,569 | |
| $0.144 | -0.010 | -6.3% | $0.149 | $0.154 | $0.138 | 1,511,718 | |
| $0.153 | -0.001 | -0.8% | $0.155 | $0.160 | $0.150 | 532,366 | |
| $0.155 | -0.003 | -2.0% | $0.150 | $0.155 | $0.142 | 737,714 | |
| $0.158 | +0.012 | +8.2% | $0.147 | $0.168 | $0.147 | 1,609,235 | |
| $0.146 | -0.005 | -3.1% | $0.147 | $0.151 | $0.142 | 305,495 | |
| $0.150 | -0.002 | -1.1% | $0.158 | $0.160 | $0.145 | 475,929 | |
| $0.152 | +0.002 | +1.3% | $0.146 | $0.155 | $0.142 | 512,403 | |
| $0.150 | -0.010 | -6.3% | $0.150 | $0.160 | $0.140 | 745,500 | |
| $0.160 | -0.020 | -11.1% | $0.180 | $0.180 | $0.150 | 2,658,100 | |
| $0.180 | +0.010 | +5.9% | $0.160 | $0.180 | $0.160 | 2,647,900 | |
| $0.170 | +0.010 | +6.3% | $0.160 | $0.180 | $0.160 | 692,300 | |
| $0.160 | 0.000 | 0.0% | $0.160 | $0.160 | $0.160 | 357,200 | |
| $0.160 | -0.010 | -5.9% | $0.160 | $0.170 | $0.150 | 822,900 | |
| $0.170 | +0.010 | +6.3% | $0.160 | $0.190 | $0.150 | 3,512,500 | |
| $0.160 | -0.010 | -5.9% | $0.170 | $0.170 | $0.160 | 356,600 | |
| $0.170 | 0.000 | 0.0% | $0.180 | $0.180 | $0.170 | 181,000 | |
| $0.170 | -0.010 | -5.6% | $0.180 | $0.180 | $0.170 | 1,096,800 | |
| $0.180 | 0.000 | 0.0% | $0.180 | $0.180 | $0.170 | 332,200 | |
| $0.180 | -0.010 | -5.3% | $0.190 | $0.190 | $0.170 | 872,700 | |
| $0.190 | -0.010 | -5.0% | $0.200 | $0.210 | $0.190 | 881,200 | |
| $0.200 | -0.010 | -4.8% | $0.210 | $0.210 | $0.200 | 374,900 | |
| $0.210 | +0.010 | +5.0% | $0.200 | $0.210 | $0.190 | 444,300 | |
| $0.200 | -0.010 | -4.8% | $0.210 | $0.210 | $0.190 | 804,500 | |
| $0.210 | 0.000 | 0.0% | $0.210 | $0.220 | $0.210 | 185,300 | |
| $0.210 | +0.010 | +5.0% | $0.200 | $0.220 | $0.200 | 558,100 | |
| $0.200 | -0.020 | -9.1% | $0.230 | $0.230 | $0.200 | 647,800 | |
| $0.220 | 0.000 | 0.0% | $0.230 | $0.230 | $0.220 | 423,900 | |
| $0.220 | -0.010 | -4.3% | $0.230 | $0.230 | $0.220 | 253,000 | |
| $0.230 | 0.000 | 0.0% | $0.230 | $0.230 | $0.220 | 559,000 | |
| $0.230 | -0.010 | -4.2% | $0.240 | $0.240 | $0.220 | 615,400 | |
| $0.240 | -0.010 | -4.0% | $0.250 | $0.260 | $0.230 | 1,242,600 | |
| $0.250 | +0.020 | +8.7% | $0.230 | $0.260 | $0.220 | 1,451,300 | |
| $0.230 | -0.030 | -11.5% | $0.260 | $0.260 | $0.220 | 1,568,400 | |
| $0.260 | 0.000 | 0.0% | $0.270 | $0.270 | $0.260 | 595,100 | |
| $0.260 | -0.010 | -3.7% | $0.270 | $0.270 | $0.250 | 6,387,800 | |
| $0.270 | -0.010 | -3.6% | $0.280 | $0.280 | $0.270 | 304,700 | |
| $0.280 | 0.000 | 0.0% | $0.290 | $0.290 | $0.270 | 389,100 | |
| $0.280 | -0.020 | -6.7% | $0.300 | $0.300 | $0.280 | 419,900 | |
| $0.300 | +0.020 | +7.1% | $0.280 | $0.300 | $0.270 | 1,401,200 | |
| $0.280 | 0.000 | 0.0% | $0.280 | $0.290 | $0.270 | 398,200 | |
| $0.280 | 0.000 | 0.0% | $0.280 | $0.290 | $0.270 | 696,900 | |
| $0.280 | 0.000 | 0.0% | $0.280 | $0.280 | $0.280 | 267,900 | |
| $0.280 | 0.000 | 0.0% | $0.280 | $0.280 | $0.270 | 606,300 | |
| $0.280 | 0.000 | 0.0% | $0.280 | $0.280 | $0.270 | 386,600 | |
| $0.280 | -0.010 | -3.4% | $0.300 | $0.300 | $0.270 | 366,400 | |
| $0.290 | 0.000 | 0.0% | $0.290 | $0.290 | $0.280 | 358,800 | |
| $0.290 | 0.000 | 0.0% | $0.290 | $0.300 | $0.290 | 230,800 | |
| $0.290 | 0.000 | 0.0% | $0.290 | $0.300 | $0.280 | 333,000 | |
| $0.290 | -0.002 | -0.5% | $0.290 | $0.300 | $0.280 | 283,100 | |
| $0.292 | 0.000 | -0.1% | $0.287 | $0.300 | $0.281 | 647,948 | |
| $0.292 | +0.002 | +0.7% | $0.284 | $0.304 | $0.276 | 969,780 | |
| $0.290 | +0.010 | +3.6% | $0.280 | $0.290 | $0.270 | 715,800 | |
| $0.280 | 0.000 | 0.0% | $0.280 | $0.280 | $0.270 | 803,200 | |
| $0.280 | 0.000 | 0.0% | $0.280 | $0.290 | $0.270 | 1,766,800 | |
| $0.280 | -0.040 | -12.5% | $0.310 | $0.320 | $0.260 | 2,062,600 | |
| $0.320 | 0.000 | 0.0% | $0.320 | $0.330 | $0.310 | 1,113,300 | |
| $0.320 | -0.010 | -3.0% | $0.330 | $0.330 | $0.320 | 1,509,800 | |
| $0.330 | 0.000 | 0.0% | $0.330 | $0.340 | $0.320 | 1,473,600 | |
| $0.330 | -0.020 | -5.7% | $0.350 | $0.350 | $0.330 | 2,248,800 | |
| $0.350 | -0.010 | -2.8% | $0.360 | $0.370 | $0.350 | 3,279,600 | |
| $0.360 | -0.110 | -23.4% | $0.410 | $0.420 | $0.350 | 6,772,200 | |
| $0.470 | +0.140 | +42.4% | $0.320 | $0.580 | $0.310 | 97,915,600 | |
| $0.330 | -0.030 | -8.3% | $0.390 | $0.390 | $0.310 | 3,033,900 |
Splits
2 splits since 2020 · NASDAQ:VIVS · every price before a split is adjusted for it
| Day | Ratio | What |
|---|---|---|
| 1-for-12 | Consolidation | |
| 1-for-20 | Consolidation |
- Ticker
- Lang & Schwarz:A41083
- Asset type
- Stock
- Sector
- Health care
- Industry
- Diagnostics & research services
- Exchange
- Lang & Schwarz
- Currency
- EUR
What changed lately
Latest news release · Nov 3, 2026
VivoSim Labs and Chemveda Life Sciences Join Forces to Put AI-Designed Drug Candidates to the Human Test
Latest deck · 2026
Investor Presentation (2026)
Investor deck · 22 slides
Latest news
VivoSim Labs and Chemveda Life Sciences Join Forces to Put AI-Designed Drug Candidates to the Human Test
Nov 3, 2026
Closed $0.144 (-6.3%) on Nov 3, 2026
VivoSim Labs Extends NAMkind Platform with Human Disease Models for Efficacy Testing and Mechanistic Biomarker Profiling
Oct 21, 2026
Closed $0.18 (+5.9%) on Oct 21, 2026
VivoSim Labs Celebrates Updated FDA Regulations Allowing Greater use of Non-Animal Testing Methods
Oct 7, 2026
Closed $0.19 (-5.0%) on Oct 7, 2026
VivoSim Labs Unveils New NAMkind™ Drug Toxicity Data at EUROTOX 2026, Demonstrating Predictive Superiority in Liver and Gastrointestinal Safety Across Small Molecules and ADCs
Sep 16, 2026
Closed $0.26 (-3.7%) on Sep 16, 2026
VivoSim Labs to Add Rat Liver Model to NAMkind Platform
Sep 1, 2026
Closed $0.28 (-3.4%) on Sep 1, 2026
VivoSim Provides Financial and Listing Compliance Update
Aug 6, 2026
Closed $0.33 (-8.3%) on Aug 6, 2026
VivoSim Enters China with First Commercial Sales of NAMkind™ Toxicology Screening and Efficacy Testing Services
Jul 21, 2026
Closed $0.45 (-10.0%) on Jul 21, 2026
VivoSim Announces Pricing of $4.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules with a Single Healthcare Focused Institutional Investor
Jul 16, 2026
Closed $0.61 (-28.2%) on Jul 16, 2026
VivoSim Receives $5M Milestone Payment from Eli Lilly; Provides Guidance That It Expects Revenue Growth of 500%+ in FY2027
Jul 15, 2026
Closed $0.85 (+2.4%) on Jul 15, 2026
VivoSim Presents Data Showing Superiority to Competition in NAM Liver Tox Prediction at European Toxicology Meeting
Jun 29, 2026
Closed $1.06 (+2.9%) on Jun 29, 2026
Financings
Private placement of pre-funded warrants and common warrants
Aug 6, 2026
Closed: US$4M raised · US$0.85 a share · Warrants at US$0.85 for 60 months · A.G.P./Alliance Global Partners
Dealers: A.G.P./Alliance Global Partners (lead)
Use of proceeds: Working capital and general corporate purposes
Warrant exercise of common stock issued on warrant exercises and at-the-market sales
Mar 6, 2025
Closed: US$2.3M raised
Decks
Investor Presentation (2026)
Investor deck · 22 slides · 2026
VivoSim Labs, Inc. on 6ix
- Sector
- Health care
- Industry
- Diagnostics & research services
- News releases
- 18 in the last 12 months · 64 in all · newest Nov 3, 2026 · oldest 2019
- Decks
- 1 deck · latest 2026
Where VivoSim Labs, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:VIVS · Home listing | NASDAQ | United States | USD |
| Munich:4OR | Munich | Germany | EUR |
| LSE:0R02 | LSE | United Kingdom | USD |
| gettex:4OR | gettex | Germany | EUR |
| BOATS:VIVS | BOATS | United States | USD |
| Frankfurt:4OR | Frankfurt | Germany | EUR |
| LS Exchange:A41083 | LS Exchange | Germany | EUR |
| Lang & Schwarz:A41083 · This page | Lang & Schwarz | Germany | EUR |
| Stuttgart:4OR | Stuttgart | Germany | EUR |
Log in to ask 6ix AI your own questions about VivoSim Labs, Inc.